Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Wyllie

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
BJU International|November 25, 2003
Ejaculatory dysfunction: why all alpha-blockers are not equalK-E Andersson, M G Wyllie
Neuropharmacology|April 1, 1982
Resolution of monoamine uptake into binding and translocation componentsM D Wood, M G Wyllie
British Journal of Pharmacology|June 1, 1980
The relationship between nerve terminal adenosine triphosphatases and neurotransmitter release: as determined by the use of antidepressant and other CNS-active drugsJ C Gilbert, M G Wyllie
British Journal of Pharmacology|November 1, 1979
Inhibition of synaptosome ATPase by PGE1 may be dependent on a soluble factor [proceedings]J C Gilbert, M G Wyllie
Journal of Neurochemistry|April 1, 1986
Subcellular site of action of imipramine in rodent brainM D Wood, M G Wyllie
Neuropharmacology|March 1, 1986
A reassessment of the binding of [3H]rauwolscine to membranes from the rat cortexA M Broadhurst, M G Wyllie
Biochemical Pharmacology|May 1, 1980
Exocytotic release of noradrenaline from synaptosomesM G Wyllie, J C Gilbert
The Prostate|February 15, 1997
Prostatic alpha 1-adrenoceptors and uroselectivityK E Andersson, H Lepor, M G Wyllie
Drug News & Perspectives|June 14, 2003
Directions in urological research and drug therapiesM Gopalakrishnan, S A Buckner, M G Wyllie
Urology|November 1, 1996
Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industryJ C McGrath, H Lepor, M G Wyllie
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
BJU International|November 25, 2003
Ejaculatory dysfunction: why all alpha-blockers are not equalK-E Andersson, M G Wyllie
Neuropharmacology|April 1, 1982
Resolution of monoamine uptake into binding and translocation componentsM D Wood, M G Wyllie
British Journal of Pharmacology|June 1, 1980
The relationship between nerve terminal adenosine triphosphatases and neurotransmitter release: as determined by the use of antidepressant and other CNS-active drugsJ C Gilbert, M G Wyllie
British Journal of Pharmacology|November 1, 1979
Inhibition of synaptosome ATPase by PGE1 may be dependent on a soluble factor [proceedings]J C Gilbert, M G Wyllie
Journal of Neurochemistry|April 1, 1986
Subcellular site of action of imipramine in rodent brainM D Wood, M G Wyllie
Neuropharmacology|March 1, 1986
A reassessment of the binding of [3H]rauwolscine to membranes from the rat cortexA M Broadhurst, M G Wyllie
Biochemical Pharmacology|May 1, 1980
Exocytotic release of noradrenaline from synaptosomesM G Wyllie, J C Gilbert
The Prostate|February 15, 1997
Prostatic alpha 1-adrenoceptors and uroselectivityK E Andersson, H Lepor, M G Wyllie
Drug News & Perspectives|June 14, 2003
Directions in urological research and drug therapiesM Gopalakrishnan, S A Buckner, M G Wyllie
Urology|November 1, 1996
Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industryJ C McGrath, H Lepor, M G Wyllie
Pageof 7